Refine by
Leukemia Aml Services
6 services found
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
NOMO-1 established from the bone marrow of a 31-year-old woman with acute myeloid leukemia (AML FAB M5a) at 2nd relapse; described to show strong lysozyme activity in the cytoplasm, phagocytic activities, and cells are responsive to induction of differentiation with TPA; cells carry the t(9;11)(q23;p22) MLL-MLLT3 (MLL-AF9) alteration ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Cytarabine Hydrochloride: Cytarabine hydrochloride is a white to off-white crystalline with the chemical name 1-β-D-arabinofuranosyl-4-amino-2(1H)-pyrimidinone hydrochloride. Cytarabine hydrochloride is used in chemotherapy for white blood cell cancers, especially acute myeloid leukemia (AML). ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Ancitabine hydrochloride is the hydrochloride salt of a cytarabine congener prodrug, so it has similar antineoplastic activity to cytarabine. It is widely used in chemotherapy for treating white blood cell cancers, especially acute myeloid leukemia (AML). ...
by:Vor Biopharma based inCambridge, MASSACHUSETTS (USA)
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. On-target toxicity has led to ...
by:Champions Oncology, Inc. based inHackensack, NEW JERSEY (USA)
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...